Navigation Links
Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
Date:6/16/2008

ctive estrogen beta modulators."

About Bionovo

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, which are markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no oblig
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
2. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
3. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
4. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
5. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
6. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
7. Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
8. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
9. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... CHICAGO, Dec. 14 Sword Diagnostics, Inc. ... Patent Office (USPTO) has issued patent number ... Biological Organisms using Raman Scattering" to the company. ... on improved sensitivity. ,, "The issuance of ... move forward with our continued development and commercialization," ...
(Date:12/14/2009)... -- Gibraltar Associates, a leading public affairs ... communications and issues management, today announced that ... Corporation (Nasdaq: PSID ) to serve ... record. Gibraltar Associates will conduct media relations ... Company on its public relations programs. ,, ...
(Date:12/14/2009)... /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC ... received a complete response letter from the U.S. ... New Drug Application ("NDA") for Onrigin(TM) (laromustine) injection ... that the FDA cannot approve the Company,s NDA ... address remaining issues. ,, Alan Kessman, Chief Executive ...
Breaking Medicine Technology:Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3New Stress Busting Drink Tranquila 28TM 29 Quenches Jangled Nerves 56354 1New Stress Busting Drink Tranquila 28TM 29 Quenches Jangled Nerves 56354 2New Stress Busting Drink Tranquila 28TM 29 Quenches Jangled Nerves 56354 3Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells 13883 1Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells 13883 2Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells 13883 3Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells 13883 4Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan 13881 1Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan 13881 2Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan 13881 3Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan 13881 4Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan 13881 5
... WALTHAM, Mass., Nov. 6 Inverness Medical,Innovations, Inc. ... marketer of rapid,diagnostic products for the consumer and ... World Markets, 18th Annual Healthcare,Conference on November 7, ... Jon Russell, Vice President of Finance, will attend. ...
... Clinical Evaluation Anticoagulant Inhibits Clotting Factor IXa; ... Reverses Anticoagulant Effect, ORLANDO, Fla., Nov. 6 ... Phase Ib dose escalation,studies of the Company,s REG1 Anticoagulation ... anticoagulant, RB006,and its matched antidote, RB007, which binds to ...
Other Medicine Technology:Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions 2Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions 3
(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- ... -- the largest survey on teen drug abuse tracking ... that teens, intentional abuse of prescription (Rx) and over-the-counter ... with an alarming number of young people abusing medicines ... Teen Abuse of Medication Continues to Be a ...
(Date:12/14/2009)... Dec. 14 The Hemophilia Federation of ... labor issues involving the Teamsters Local 929 and ... The national blood system depends on skilled workers ... blood is distilled into products such as clotting ... Willebrand disease. ,, The Division of Blood ...
(Date:12/14/2009)... treated, hadn,t spread, study finds , , MONDAY, Dec. 14 ... of death in male colon cancer survivors, researchers report. ... 668 men who,d been treated for stage I, stage ... spread (nonmetastatic cancer). Every two years, the men were ... and disease diagnoses, as well as their physical activity. ...
(Date:12/14/2009)... offer some protection, study finds, , , MONDAY, Dec. 14 ... can,t start their morning without a cup or two ... risk of developing type 2 diabetes. , That,s ... the more coffee you drink, the lower your risk ... a 7 percent reduction in the risk of diabetes, ...
(Date:12/14/2009)... disorders are underdiagnosed, poorly treated and highly stigmatized, ... Eugene H. Rubin, M.D., Ph.D. So these Washington ... those problems. , In "Demystifying Psychiatry," Zorumski and ... experience treating psychiatric patients and helping patient families, ... illness and treatment result from a lack of ...
Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3
... SectorWatch.biz announces the,availability of MarketStats for Healthier ... MarketStats offers a perspective on the,aforementioned equities and ... opinions on the subject and sector creating a ... MarketStats by visiting: http://www.SectorWatch.biz ,-- a division ...
... The Board of,Directors of Rural/Metro Corporation (Nasdaq: RURL ... fire protection services,announced today that Mr. Conrad A. Conrad ... joined the Rural/Metro Board of Directors in October 2005,and ... and Compensation committees.,He succeeds Mr. Cor Clement, who announced ...
... ... Lake City, UT (PRWEB) July 10, 2008 – Two Little Hands ... and hit public television show designed to teach babies , toddlers ... pleased to announce the release of two new DVDs completing Series Two ...
... Park Avenue Laser Vision (PALV) Center recently appeared on Fox ... guest to discuss the issue of offering his patients discounts ... video sharing site, YouTube. Dr. Chynn explains on the ... to reach people in their 20s, 30s, and 40s who ...
... and soccer players who have had a previous concussion ... of concussion, new research released today at the 2008 ... the JW Marriott Orlando Grande Lakes shows. The study ... for significant differences in test results following the injury. ...
... SmoothToe, the only brand,of diabetic socks available anywhere ... well as a Five Year Extended Warranty, has new ... ( http://www.SmoothToe-Socks.com ) is pleased,to announce its April 1st ... their introduction to the UK via the website:, http://www.SmoothToe.co.uk ...
Other Medicine News:Health News:SectorWatch.biz Issues MarketStats on Healthy Living Companies UKMA, LULU, GAIA, NTRI, and WTW 2Health News:Conrad A. Conrad Elected Chairman of the Board for Rural/Metro Corporation 2Health News:Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 2Health News:Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing 3Health News:Men and women with history of concussion mend differently, study finds 2Health News:SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group 2
... This latest sensor array with ... inter-channel spacing of just 2.2 ... is particularly useful when using ... Synthetic Aperture Magnetometry (SAM) or ...
... supine measurement position is achieved using an ... a non-magnetic, mobile patient bed. The patient ... shielded room. In case of an emergency ... the shielded room for e.g. resuscitation purposes. ...
... The Magnes 1300 C is ideal for ... brain and other parts of the body. Often ... its possibilites, including magnetocardiography, gastrointestinal tract, fetal, spinal ... ,The 1300 C, with its 67 detector ...
... one-of-kind portable Digital Radiography system designed for diverse ... a 14 x 17- inch imaging area and ... large imaging area and lightweight design, the CXDI-50G ... Radiography. It is large enough for chest and ...
Medicine Products: